Viewing Study NCT00558103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-01-25 @ 4:29 AM
Study NCT ID: NCT00558103
Status: COMPLETED
Last Update Posted: 2013-02-04
First Post: 2007-11-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms, Breast View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GW572016 View
None Breast Cancer View
None RECIST View
None Inflammatory Breast Cancer View
None Pazopanib View
None ErbB2 View
None Cutaneous Disease View
None Tykerb View
None Inflammatory View
None Skin View
None Her2 View
None Lapatinib View
None GW786034 View